Briacell Therapeutics Corp (BCTX)
3.55 x 1 4.50 x 1
Pre-market by (Cboe BZX)
3.65 -0.32 (-8.06%) 03/31/25 [NASDAQ]
3.55 x 1 4.50 x 1
Pre-market 3.65 unch (unch) 15:59 ET
for Mon, Mar 31st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2024 | 07-2023 | 07-2022 | 07-2021 | 07-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 862 | 21,251 | 41,042 | 57,269 | 21 |
| Receivables | 2,792 | 5,697 | 24 | 13 | 23 |
| TOTAL | $3,654 | $26,949 | $42,347 | $57,798 | $262 |
| Non-Current Assets | |||||
| PPE Net | 388 | N/A | N/A | N/A | N/A |
| Investments And Advances | 419 | 0 | 0 | 0 | 0 |
| Intangibles | 200 | 215 | 230 | 246 | 261 |
| Other Non-Current Assets | 1,212 | 0 | 0 | 0 | 0 |
| TOTAL | $2,218 | $215 | $230 | $246 | $261 |
| Total Assets | $5,872 | $27,164 | $42,577 | $58,044 | $522 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,171 | 1,124 | 463 | 214 | 3,714 |
| Accrued Expenses | 290 | 678 | 478 | 343 | N/A |
| TOTAL | $7,461 | $1,802 | $941 | $557 | $3,964 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 1,236 | 29,139 | 31,307 | 29,815 | 156 |
| TOTAL | $1,096 | $29,139 | $31,307 | $29,815 | $156 |
| Total Liabilities | $8,557 | $30,941 | $32,248 | $30,372 | $4,120 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,413 | 1,066 | N/A | N/A | N/A |
| Common Shares | 72,166 | 69,592 | 65,589 | 54,774 | 12,264 |
| Retained earnings | -85,444 | -80,652 | -60,350 | -29,142 | -18,170 |
| Other shareholders' equity | 10,592 | 7,283 | 5,089 | -139 | 2,308 |
| TOTAL | $-2,685 | $-3,777 | $10,329 | $27,672 | $-3,597 |
| Total Liabilities And Equity | $5,872 | $27,164 | $42,577 | $58,044 | $522 |